Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05491499 · ClinicalTrials.gov registry record

Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
43
Enrollment target

NCT05491499: Completed study, sponsored by Boston Children's Hospital.

NCT05491499 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05491499 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
43 participants
Enrollment target

Study Summary

This work will answer two critical questions: 1) Does intensive interdisciplinary pain treatment (IIPT) involving aerobic exercise help normalize pain processing in youth with chronic pain syndromes and 2) Are aerobic fitness levels and the ability to modulate pain inter-related? Currently, medications are ineffective for improving pain and disability in youth with chronic pain syndromes and identifying non-pharmacologic treatments, such as IIPT, that help strengthen the nervous system's ability to modulate or turn pain signals down will improve outcomes and quality of life for youth suffering from chronic pain. This study will help determine whether exercise based IIPT leads to physiologic improvements in how pain is processed, specifically if youth with chronic pain can better turn pain down during the offset analgesia test after an exercise based IIPT treatment, and also help elucidate the link between a child's aerobic fitness and their ability to modulate pain.

Primary Outcome

Percent reduction in pain following the small, 1º C stimulus offset.

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2022-10-17
Est. Completion 2023-11-30
Boston Children's Hospital

462 total trials

What the finished NCT05491499 record still lists

NCT05491499 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT05491499 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05491499 about?

NCT05491499 is a clinical study titled "Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes". This work will answer two critical questions: 1) Does intensive interdisciplinary pain treatment (IIPT) involving aerobic exercise help normalize pain processing in youth with chronic pain syndromes and 2) Are aerobic fitness levels and the ability to modulate pain inter-related? Currently, medicat...

What is the current status of trial NCT05491499?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2022-10-17. Estimated completion is 2023-11-30.

Who is sponsoring clinical trial NCT05491499?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05491499, the US trial registry maintained by the National Library of Medicine. NCT05491499 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.